The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients

[1]  M. Laakso,et al.  Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study , 1998, Diabetes Care.

[2]  S. Haffner.  Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.

[3]  L. Mandarino,et al.  Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. , 1996, The American journal of physiology.

[4]  G. Dagenais,et al.  Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study. , 1996, Atherosclerosis.

[5]  D. Bell.  A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia. , 1995, Clinical therapeutics.

[6]  G. Lewis.  Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data. , 1995, Canadian Journal of Cardiology.

[7]  A. Avogaro,et al.  Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients. , 1995, Atherosclerosis.

[8]  D. Bhatnagar,et al.  Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. , 1994, European journal of clinical nutrition.

[9]  G. Steiner.  Dyslipoproteinemias in diabetes. , 1994, Clinical and investigative medicine. Medecine clinique et experimentale.

[10]  M D Jensen,et al.  In vivo regulation of lipolysis in humans. , 1994, Journal of lipid research.

[11]  M. Taskinen,et al.  Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  J. Huttunen,et al.  Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study , 1992, Diabetes Care.

[13]  G. Steiner.  Altering Triglyceride Concentrations Changes Insulin-Glucose Relationships in Hypertriglyceridemic Patients: Double-Blind Study With Gemfibrozil With Implications for Atherosclerosis , 1991, Diabetes Care.

[14]  G. Reaven,et al.  Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus. , 1991, The Journal of clinical endocrinology and metabolism.

[15]  J. Huttunen,et al.  Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels. , 1990, Atherosclerosis.

[16]  Y. Tani,et al.  Enzymatic microdetermination of serum free fatty acids. , 1979, Analytical biochemistry.

[17]  P. Dunn,et al.  A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. , 1978, Metabolism: clinical and experimental.

[18]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[19]  G. Kostner.  Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. , 1976, Clinical chemistry.

[20]  G. Reaven,et al.  Reappraisal of the role of insulin in hypertriglyceridemia. , 1974, The American journal of medicine.

[21]  E. Horton.  NIDDM--the devastating disease. , 1995, Diabetes research and clinical practice.

[22]  P. Allhoff,et al.  Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle Aged Men with Dyslipidemia , 1991 .

[23]  L. Amorosa,et al.  Management of noninsulin-dependent diabetes mellitus. , 1980, American family physician.

[24]  M. Knob,et al.  Enzymatische Bestimmung des Gesamtcholesterins im Serum mit Zentrifugalanalyzern , 1975 .

[25]  A. Wahlefeld.  Triglycerides Determination after Enzymatic Hydrolysis , 1974 .